hotspot -WSS

hotspot

author：Wikipedia 2025-09-02 13:53:48 - browse：27

Duchenne muscular dystrophy is a devastating disease and, until very recently, was one without much hope. When Hawken Miller was diagnosed at age 5, the physician told his parents to enjoy the time they had with him, as there wouldn’t be much. Over 20 years later, Miller is a journalist and content strategist for CureDuchenne, an organization started by his mother when he was diagnosed, and new treatment is on the horizon.

Last month, the FDA approved a new gene therapy from Sarepta Therapeutics that will provide hope for many patients and families. The new drug, however, has its limitations — it’s only approved for children age 4-5, for example. Miller joined the podcast to discuss how this drug may change lives, what more needs to happen, and what his personal experience has been living with Duchenne.

“For the older boys, we’re running up against the clock a little bit with what we’re able to do and what we’re not able to do,” Miller said. “And if we’re able to try anything that could possibly help, I think most people would like the opportunity to do that.”

The conversation is based off his recent First Opinion, “The FDA’s approval of a new gene therapy for Duchenne muscular dystrophy won’t help me — but it gives me hope.”

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Stitcher, Google Play, or wherever you get your podcasts.

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

entertainment

WSS

Readout Newsletter: BridgeBio, Akero, and human embryo models

IVF doctors demand details after CooperSurgical lawsuit

Medicare drug price negotiation hearing pits pharma v Biden admin

Medicare drug price negotiation hearing pits pharma v Biden admin

NVIDIA and Google execs on the future of AI and drug discovery

The Readout: Lisata, Eisai x Biogen, and the Met Gala (!)

hotspot

hotspot

focus

United colonoscopy coverage change 'may cost lives,' doctors say

Families look for replacement for GSK asthma drug Flovent

Medicare details structure of new drug price negotiation program

HIV vaccine remains elusive. Immunologists keep trying new ideas

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

Duchenne breakthrough therapy leaves behind pioneering families

Helping hospitals and community health centers plan for resilience

DIEP, the 'gold standard' of breast reconstruction, is under threat

Arc Institute generative AI designs new CRISPR systems

Wikipedia

Ozempic has benefits for kidney disease as well as diabetes

Wellcome Trust’s new CEO hopes Big Tech gets more involved in public health

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

Longer MASH drug regimen improved liver, Akero study finds

He's 19 months old and has one of the world’s rarest diseases

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Wikipedia

explore

entertainment

focus